EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma

Caddie Laberiano-Fernandez, Qiong Gan, Sophia Mei Wang, Auriole Tamegnon, Ignacio Wistuba, Esther Yoon, Sinchita Roy-Chowdhuri, Edwin Roger Parra

Journal of the American Society of Cytopathology · 2024

DOI: 10.1016/j.jasc.2024.02.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Cytopathology, 2024. Verfasst von Caddie Laberiano-Fernandez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Hauptthemen laut MEDLINE: Breast Neoplasms, Pleural Effusion, Malignant, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Malignant pleural effusion (MPE) is a frequent complication of advanced malignancies. In this pilot study, we characterized the immune landscapes of MPEs, compared them to their primary tumor (PT) samples from breast carcinoma (BC) and lung adenocarcinoma (LADC), and tested the utility of multiplexed image technology in cytological samples. MATERIALS AND METHODS: We evaluated the immune contexture of 6 BC and 5 LADC MPEs and their PTs using 3 multiplex immunofluorescence panels. We explored the associations between sample characteristics and pleural effusion-free survival. RESULTS: No MPE samples had positive programmed death-ligand 1 expression in malignant cells, although 3 of 11 PTs has positive programmed death-ligand 1 expression (more than 1% expression in malignant cells). Overall, in LADC samples, cluster of differentiation 3 (CD3)+ T cells and CD3+CD8+ cytotoxic T cells predominated (median percentages for MPEs versus PTs: 45.6% versus 40.7% and 4.7% versus 6.6%, respectively) compared with BC. CD68+ macrophages predominated in the BC samples (medians for MPEs 61.2% versus PTs for 57.1%) but not in the LADC samples. Generally in PTs, CD3+CD8+ forkhead box P3+ T cells and the median distances from the malignant cells to CD3+CD8+Ki67+ and CD3+ programmed cell death protein 1 + T cells correlated to earlier MPE after PT diagnosis. CONCLUSIONS: The immune cell phenotypes in the MPEs and PTs were similar within each cancer type but different between BC versus LADC. An MPE analysis can potentially be used as a substitute for a PT analysis, but an expanded study of this topic is essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPleural Effusion, MalignantLung NeoplasmsAdenocarcinoma of LungHumansFemalePilot ProjectsMiddle AgedAgedB7-H1 AntigenMaleAdenocarcinomaAdultAged, 80 and overBiomarkers, Tumor

Stichwörter der Autor:innen

BreastCancerImmunofluorescenceLungMicroenvironmentPleural effusion

Substanzen

B7-H1 AntigenCD274 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: erparra@mdanderson.org.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Laberiano-Fernandez, C., Gan, Q., Wang, S. M., Tamegnon, A., Wistuba, I., Yoon, E., Roy-Chowdhuri, S., & Parra, E. R. (2024). Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma. Journal of the American Society of Cytopathology. https://doi.org/10.1016/j.jasc.2024.02.005

Vancouver

Laberiano-Fernandez C, Gan Q, Wang SM, Tamegnon A, Wistuba I, Yoon E, et al. Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma. Journal of the American Society of Cytopathology. 2024. doi:10.1016/j.jasc.2024.02.005

BibTeX
@article{LaberianoFernandez2024,
  author = {Laberiano-Fernandez, Caddie and Gan, Qiong and Wang, Sophia Mei and Tamegnon, Auriole and Wistuba, Ignacio and Yoon, Esther and Roy-Chowdhuri, Sinchita and Parra, Edwin Roger},
  title = {Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma},
  journal = {Journal of the American Society of Cytopathology},
  year = {2024},
  doi = {10.1016/j.jasc.2024.02.005}
}
Kostenlos starten →